However, in SCD inhibitor–treated mice, where late-stage tumors overexpress SCD (see Fig. 4G), and presumably acquire resistance in vivo through FOSB overdrive (see Fig. 6D), FOSB shRNA slowed tumor growth and improved survival of mice (Fig. 7, E and F). The gene discussed is FOSB; the disease is neoplasm.